Veronica Soloveva

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), United States Army Medical Research Institute of Infectious Diseases

发表论文 65 篇 · 总被引 3759 次 · h-index 25

代表论文

• The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus (2019 · iScience · 被引 140)
• Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes (2018 · Science Advances · 被引 93)
• The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines (2020 · Virus Research · 被引 73)
• Selective Targeting of Virus Replication by Proton Pump Inhibitors (2020 · Scientific Reports · 被引 40)
• Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo (2019 · Antiviral Research · 被引 36)
• Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics (2018 · Antiviral Research · 被引 36)